Devices › Device types
FDA product code MAE · class 3 · Unknown
Occluder, patent ductus, arteriosus: medical device reports filed with FDA
1,091 reports carry this product code, 2001–2026; 7 brands with a page.
- 1,091
- reports with this product code
- 0% of all MAUDE reports
- 202
- reports, 12 months to August 2026
- 147 in the 12 months before
- 33.5%
- classified as malfunction
- 62.3% across all reports
- 5.7%
- classified as death, as reported
- 0.9% across all reports
Product code MAE is FDA's classification for "Occluder, patent ductus, arteriosus" (unknown panel), a class 3 device. 1,091 medical device reports carry this product code, 0% of the MAUDE database, from April 2001 to August 2026.
202 reports arrived in the 12 months to August 2026, up 37% from 147 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (60.6%), malfunction (33.5%) and death (5.7%). 7 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Amplatzer Duct Occluder | 496 | 83 | 2.1% | 40.4% |
| Amplatzer Piccolo | 220 | 56 | 13.6% | 19.1% |
| Amplatzer Septal Occluder | 5 | 406 | 2.4% | 43.4% |
| Amplatzer Cribriform Occluder | 1 | 0 | 0.4% | 37.3% |
| Amplatzer PFO Occluder | 1 | 42 | 2.8% | 45.7% |
| Ipump Pain Management System | 1 | 0 | 0.5% | 97.5% |
| Malleable Penile Prosthesis | 1 | 0 | 0% | 0.7% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Aga Medical | 349 | 32% |
| Abbott Medical | 68 | 6.2% |
| Abbott Laboratories | 1 | 0.1% |
| Baxter Healthcare Pte | 1 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Migration or expulsion of device | 376 | 34.5% |
| Difficult to fold, unfold or collapse | 210 | 19.2% |
| Patient device interaction problem | 95 | 8.7% |
| Off-label use | 71 | 6.5% |
| Improper or incorrect procedure or method | 57 | 5.2% |
| Material deformation | 52 | 4.8% |
| Unintended movement | 43 | 3.9% |
| Malposition of device | 28 | 2.6% |
| Inadequacy of device shape and/or size | 27 | 2.5% |
| Device dislodged or dislocated | 21 | 1.9% |
| Migrationthe device moved from where it was placed | 20 | 1.8% |
| Obstruction of flow | 19 | 1.7% |
| Patient-device incompatibilitythe device did not suit the patient | 17 | 1.6% |
| Insufficient device problem information | 14 | 1.3% |
| Difficult to removethe device was hard to remove | 12 | 1.1% |
| Premature separation | 12 | 1.1% |
| Human-device interface problem | 11 | 1% |
| Biocompatibility | 9 | 0.8% |
| Activation, positioning or separation problem | 8 | 0.7% |
| Device operates differently than expectedthe device behaved unexpectedly | 8 | 0.7% |
Questions about occluder, patent ductus, arteriosus reports
What is product code MAE?
FDA's classification code for "Occluder, patent ductus, arteriosus", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.
How many reports carry this code?
1,091 reports through August 2026, 202 of them in the latest 12 months.
Which brands appear most often?
Amplatzer Duct Occluder (496), Amplatzer Piccolo (220), Amplatzer Septal Occluder (5), Amplatzer Cribriform Occluder (1) and Amplatzer PFO Occluder (1). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.